Skip to main content
. 2009 Mar;58(3):732–737. doi: 10.2337/db08-0493

FIG. 4.

FIG. 4.

Prevalence of autoantibody against human AMY-2A in patients with various types of diabetes. Prevalence of autoantibody against human AMY-2A (•) in patients with fulminant type 1 diabetes (FT1DM, n = 17), acute-onset type 1 diabetes (AT1DM, n = 42), type 2 diabetes (T2DM, n = 67), and control subjects from healthy volunteers (C, n = 100) was studied by ELISA, as described in research design and methods. The data are the mean of triplicate values. The dotted line shows a cutoff value. Fisher's exact test was carried out between fulminant type 1 diabetic and control groups. *P < 0.001.